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Objectives: To eval,uate the util,ity of BGL monitor- 
ing in neutropenic cancer pts at high risk of IA and 
IC. 
Methods: Prospective study of consecutive episodes 
of neutropenia (median duration 22 d) in pts with 
acute l,eukemia. IA and IC were defined accord- 
ing to EORTC-MSG criteria. Bl,ood was col,l,ected 
2 times weekl,y before onset of fever and dail,y 
thereafter. BGL was measured by turbidimetric 
or col,orimetric assays (Wako, Japan). Positive 
tests defined by 2 consecutive BGL val,ues >6 and 
>5 pg/ml,, or >11 pg/ml, for both tests (2 cut-off 
val,ues). 
Results: 23 episodes of invasive mycoses oc- 
curred during 130 neutropenic episodes: 12 IC 
(1 proven, 11 probabl,e) and 11 IA (3 proven, 
8 probabl,e). 16 sampl,es/episode (3-35) were an- 
al,yzed over 35 days (17-122). Diagnostic per- 
formance of BGL (turbidimetric test): sensitivity, 
specificity, PPV, NPV, negative l,ikel,ihood ratio were 
43/100/100/86/0.57% and 24/100/100/82/0.76% 
for 2 consecutive val,ues >6 and >11, respec- 
tivel,y. Diagnostic performance of BGL (col,orimet- 
ric test): sensitivity, specificity, PPV, NPV, nega- 
tive l,ikel,ihood ratio were 86/91/72/96/0.15% and 
43/100/100/86/0.57% for 2 consecutive val,ues 
>5 and >11, respectivel,y. Col,orimetric BGL with 
cut-off of 2 consecutives val,ues >5 provided the 
best performance for diagnosis of IA and IC. Me- 
dian time (0d) between fever onset (as first sign 
of IFI) and BGL positivity was significantl,y shorter 
than that between fever onset and conventional. 
diagnosis of IFI (13d) (p < 0.0001). 
Conclusions: Serial. screening of bl,ood beta-l,3-D- 
gl,ucan is a promising non-invasive tool,, in combi- 
nation with other diagnostic methods, to identify 
persistentl,y febril,e neutropenic pts in whom em- 
pirical, therapy may be unnecessary. 
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Objectives: To define the magnitude of the prob- 
l,em, study factors associated with increased risk of 
invasive fungal, infections (IFI) and outcome. 
Methods: From June 1998 to March 2003, al,l, ra- 
diol,ogical, studies of patients with hematol,ogic/ 
oncol,ogic disorders were eval,uated for incl,usion. 
AI,I, cases of invasive fungal, infection were re- 
viewed. The criteria for incl,usion were obvious 
l,esion suggestive of fungal, infection shown on radi- 
ol,ogical, studies, and fungal, infections were cl,assi- 
fled as "proven", "probabl,e', "possibl,e" or "insuf- 
ficient evidence" according to a prior definitions. 
Results: A total, of 1615 patient charts were re- 
viewed. The underl,ying diagnoses incl,ude ALL 410, 
SCT 293, AML 133, non-mal,ignant hematol,- 
ogy 288, NHL/sol,id tumors 491. 152 (9%) had ev- 
idence of fungal, infection (55 [36%] 'definite = 
proven/probabl,e', 97 [64%] 'possibl,e'). Biopsy was 
performed in 94 cases and the findings incl,uded 
budding yeast in 10 patients, septated hyphae 
in 19, and hyphae with no specifications in 12 pa- 
tients. Del,ays in performing diagnostic procedures 
possibl,y resul,ted in the l.ower incidence of 'def- 
inite' IFI (36% vs 64% 'possibl,e"). The overal,l, in- 
cidence of fungal, infection was 9%, being high- 
est for AML (39%), fol,l,owed by ALL (17%). The 
majority of IFI devel,oped during or immediatel,y 
after induction (42% of IFI in AML and 53% of IFI 
in ALL), which can be a target for intervention. 
The infections incl,uded disseminated fungal, infec- 
tion (36%), CDC (11%), pul,monary fungal, infec- 
tion (43%) and asper~illosis (9.5%) incl,uding pul.- 
monary, Para nasal, sinuses, skin and disseminated. 
IFI was radiol,ogical,l,y diagnosed during neutropenia 
in 123 patients (81%). Ten patients died due to 
fungal, infection (7%), 75 (49%) were cured, 26 (17%) 
were al,ive with fungal, infection, and 39 patients 
(26%) died due to primary disease seemingl,y un- 
rel,ated to fungal, infection. Mortal,ity due to IFI 
in this study is l,ess than what is reported in the 
l,iterature and coul,d be a resul,t of our practice 
of earl,y intervention. The average LOS for IFI was 
56 days compared with the usual. 12 days, which 
can add to the increased cost. 
Conclusions: Invasive fungal, infection is becoming 
a serious probl,em. Furthermore, acute invasive 
fungal, infection is associated with a much higher 
mortal,ity. Earl,y diagnosis with prompt antifungal, 
therapy, or even with surgical, intervention, might 
be warranted to save patients' l,ives. 
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Background: Daptomycin is a novel, l,ipopep- 
tide recentl,y approved for treatment of compl,i- 
cated skin and skin structure infections (SSTIs) 
